REGENGLOW Trademark

Trademark Overview

On Friday, September 19, 2025, a trademark application was filed for REGENGLOW with the United States Patent and Trademark Office. The USPTO has given the REGENGLOW trademark a serial number of 99402630. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, September 19, 2025. The REGENGLOW trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Skin treatment, namely the injection of blood-derived growth factors including platelet rich fibrin matrix and albumin into the face for the purpose of rejuvenation of the face
regenglow

General Information

Serial Number99402630
Word MarkREGENGLOW
Filing DateFriday, September 19, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, September 19, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesSkin treatment, namely the injection of blood-derived growth factors including platelet rich fibrin matrix and albumin into the face for the purpose of rejuvenation of the face

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 19, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressFullerton, CA 92833

Trademark Events

Event DateEvent Description
Friday, September 19, 2025NEW APPLICATION ENTERED
Friday, September 19, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

regenglow face fibrin rich matrix albumin purpose platelet rejuvenation including injection